carbostyril has been researched along with Skin Diseases, Bacterial in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YH; Hsueh, PR; Huang, CH; Lai, CC | 1 |
| Amano, A; Ikeda, F; Ishii, R; Kanayama, S; Matsumoto, S; Matsumoto, T; Matsuzaki, K; Nakajima, A; Okamoto, K | 1 |
| Biedenbach, DJ; Jones, RN; Kirby, JT; Mutnick, AH; Pfaller, MA | 1 |
| Schweiger, ES; Weinberg, JM | 1 |
| Dick, GC | 1 |
| Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 1 |
| Dorr, MB; Lipsky, BA; Magner, DJ; Talbot, GH | 1 |
2 review(s) available for carbostyril and Skin Diseases, Bacterial
| Article | Year |
|---|---|
The potential role of nemonoxacin for treatment of common infections.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Clostridium Infections; Community-Acquired Infections; Drug Therapy, Combination; Gonorrhea; Humans; Levofloxacin; Pneumonia, Bacterial; Quinolones; Skin Diseases, Bacterial | 2015 |
Novel antibacterial agents for skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Oxazolidinones; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Virginiamycin | 2004 |
5 other study(ies) available for carbostyril and Skin Diseases, Bacterial
| Article | Year |
|---|---|
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Topics: Administration, Cutaneous; Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Child; Female; Fluoroquinolones; Humans; Japan; Levofloxacin; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolizines; Quinolones; Skin Cream; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Streptococcus pyogenes | 2016 |
Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Indoles; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections | 2002 |
Use of enrofloxacin.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Pyoderma; Quinolones; Skin Diseases, Bacterial | 1993 |
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
Topics: Administration, Oral; Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Bites, Human; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Wound Infection | 1997 |
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Data Interpretation, Statistical; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Photosensitivity Disorders; Pneumonia, Bacterial; Quinolones; Sinusitis; Skin Diseases, Bacterial | 1999 |